[18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer

Chitra Viswanathan; Silvana Faria; Catherine Devine; Madhavi Patnana; Tara Sagebiel; Revathy B Iyer; Priya R Bhosale

doi:10.1016/j.cpet.2017.11.004

[18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer

PET Clin. 2018 Apr;13(2):165-177. doi: 10.1016/j.cpet.2017.11.004. Epub 2018 Feb 3.

Authors

Chitra Viswanathan¹, Silvana Faria², Catherine Devine², Madhavi Patnana², Tara Sagebiel², Revathy B Iyer², Priya R Bhosale²

Affiliations

¹ Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1473, Houston, TX 77030-4008, USA. Electronic address: Chitra.Viswanathan@mdanderson.org.
² Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1473, Houston, TX 77030-4008, USA.

Abstract

This article provides an overview of PET in cervical cancer, primarily with regard to the use of ¹⁸F-2-fluoro-2-deoxy-d-glucose-PET/computed tomography. A brief discussion of upcoming technologies, such as PET/MR imaging, is presented.

Keywords: Cancer staging; Cervical cancer; PET/CT; PET/MR imaging; Treatment planning.

Publication types

Review

MeSH terms

Aged
Aged, 80 and over
Female
Fluorodeoxyglucose F18*
Humans
Middle Aged
Positron Emission Tomography Computed Tomography / methods*
Practice Guidelines as Topic
Radiographic Image Enhancement / methods*
Uterine Cervical Neoplasms / diagnostic imaging*
Uterine Cervical Neoplasms / pathology*

Substances

Fluorodeoxyglucose F18

Grant support

P30 CA016672/CA/NCI NIH HHS/United States